Homepage
Catalog of Screening Compounds Screening Libraries Focused and Target Libraries Active Reference Sets Diversity Libraries
Screening Compounds Building blocks
Drug Discovery Services Custom Chemistry Medicinal chemistry In silico Drug Design (CADD) Discovery Biology Animal Models Toxicology and Safety ADME, DMPK Chemistry, Manufacturing and Controls
Company News & Media Contact us For suppliers Trends in discovery compounds
Homepage > Company > Media > Pharma News > 2016

Pharma News, 2016

Western-style diet linked to state-dependent memory inhibition
Western-style diet linked to state-dependent memory inhibition
Obesity may ultimately be a disease of the brain, involving a progressive deterioration of various cognitive processes that influence eating.
Alzheimer's gene may shrink brain starting in childhood
Alzheimer's gene may shrink brain starting in childhood
A gene associated with Alzheimer's disease may shrink brain structures and lower thinking skills as early as in childhood, decades before the illness actually appears, says a research.
Teva Pharmaceuticals shares up after it raises second-quarter estimates
Teva Pharmaceuticals shares up after it raises second-quarter estimates
Shares of Teva Pharmaceuticals rose nearly 4 percent Wednesday in early trading after it increased its fiscal second-quarter earnings and revenue forecasts.
The drug company that shocked the world with its prices dodged $10 billion in taxes, report says
The drug company that shocked the world with its prices dodged $10 billion in taxes, report says
Over the last few years, Gilead Sciences has grown into one of the world’s largest pharmaceutical companies, fueled by the sales of expensive specialty treatments for hepatitis C.
Bayer Sweetens Its Bid for Monsanto to $64 Billion
Bayer Sweetens Its Bid for Monsanto to $64 Billion
German drug and crop chemical group Bayer AG on Thursday announced details of a sweetened $64 billion bid for Monsanto as it tries to put the U.
Phase III clinical study of promising prostate cancer drug reveals surprising results
Phase III clinical study of promising prostate cancer drug reveals surprising results
A recently published international clinical Phase III trial of a promising drug for treating advanced prostate cancer ended with surprising results.
Scientists discovers earliest sign of Alzheimer's disease
Scientists discovers earliest sign of Alzheimer's disease
Toronto.
GE aims for $1 billion cell therapy 'tools' business with Swiss deal
GE aims for $1 billion cell therapy 'tools' business with Swiss deal
General Electric's (GE.
Shares of Juno Therapeutics jump after FDA removes clinical hold on cancer drug trial
Shares of Juno Therapeutics jump after FDA removes clinical hold on cancer drug trial
Juno Therapeutics Inc (JUNO.
Researchers make advance in possible treatments for Gaucher, Parkinson's diseases
Researchers make advance in possible treatments for Gaucher, Parkinson's diseases
With assistance from a high tech robot known at Tox21, National Institutes of Health researchers have identified and tested a molecule that shows promise as a possible treatment for the rare Gaucher d...
Teva expects Allergan deal close any day, it says while lifting guidance
Teva expects Allergan deal close any day, it says while lifting guidance
Teva and Allergan are extending the deadline once again for their $40.
Cipla to pump $89M into building South African biosimilars plant
Cipla to pump $89M into building South African biosimilars plant
India’s Cipla said it will invest $89 million (1.
Catalog of Screening Compounds Screening Libraries Screening Compounds Building blocks
Drug Discovery Services News & Media Contact us
Payment systems
Policies & Terms     ©2023 ChemDiv     ChemistryOnDemand